AI and U.S. Healthcare Costs: NEJM Catalyst | July 2026

Introduction:

Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and market dynamics may instead increase healthcare spending despite improving quality and access.

Key Takeaways:

• AI is likely to improve healthcare quality, efficiency, and patient access, but these benefits will not automatically translate into lower healthcare costs.
• Under the current fee-for-service (FFS) payment model, AI may actually increase healthcare utilization and total spending by expanding diagnostic testing, patient monitoring, and clinical services.
• AI has the potential to accelerate drug discovery and personalized medicine, but these innovations may initially increase pharmaceutical expenditures.
• Administrative automation may improve operational efficiency, yet cost savings may not be passed on to patients because of existing healthcare market structures.
• Value-based care provides a stronger financial framework for AI to reduce unnecessary care, improve outcomes, and slow long-term spending growth.
• Highly consolidated hospital systems and insurance markets may limit the ability of AI-driven efficiencies to reduce healthcare expenditures.
• Policymakers and payers will need to redesign payment models, reimbursement policies, and regulatory frameworks if AI is expected to generate meaningful cost savings.
• Without aligning financial incentives, AI is more likely to improve healthcare than reduce its cost.

Clinical Impact:

AI should be viewed primarily as a tool to enhance clinical outcomes, expand access, and improve efficiency rather than an immediate solution for reducing healthcare expenditure. The economic impact of AI will depend more on healthcare policy and reimbursement reform than on technological capability alone.

Bottom Line:

Artificial intelligence alone will not solve the healthcare cost crisis. Its ability to reduce spending depends on transitioning from fee-for-service to value-based care, supported by policies that align AI innovation with better outcomes rather than greater healthcare utilization.